PH23404A - Q-substituted tetrahydropyridine oxine cholinergic agents - Google Patents

Q-substituted tetrahydropyridine oxine cholinergic agents

Info

Publication number
PH23404A
PH23404A PH36177A PH36177A PH23404A PH 23404 A PH23404 A PH 23404A PH 36177 A PH36177 A PH 36177A PH 36177 A PH36177 A PH 36177A PH 23404 A PH23404 A PH 23404A
Authority
PH
Philippines
Prior art keywords
oxine
cholinergic agents
substituted tetrahydropyridine
tetrahydropyridine
substituted
Prior art date
Application number
PH36177A
Other languages
English (en)
Inventor
Stephen Clark Bergmeier
David Alexis Downs
Walter Hamilton Moos
David Winslow Moreland
Haile Tecle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/939,507 external-priority patent/US4710508A/en
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PH23404A publication Critical patent/PH23404A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PH36177A 1986-12-08 1987-12-07 Q-substituted tetrahydropyridine oxine cholinergic agents PH23404A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/939,507 US4710508A (en) 1986-12-08 1986-12-08 O-substituted tetrahydropyridine oxime cholinergic agents
US07/091,893 US4786648A (en) 1986-12-08 1987-09-04 O-substituted tetrahydropyridine oxime cholinergic agents

Publications (1)

Publication Number Publication Date
PH23404A true PH23404A (en) 1989-07-26

Family

ID=26784455

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36177A PH23404A (en) 1986-12-08 1987-12-07 Q-substituted tetrahydropyridine oxine cholinergic agents

Country Status (11)

Country Link
US (1) US4786648A (de)
EP (1) EP0271798B1 (de)
KR (1) KR960000072B1 (de)
AU (1) AU607442B2 (de)
DE (1) DE3785312T2 (de)
DK (1) DK638487A (de)
FI (1) FI85467C (de)
NO (1) NO172045C (de)
NZ (1) NZ222756A (de)
PH (1) PH23404A (de)
PT (1) PT86311B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
US5219873A (en) * 1987-04-24 1993-06-15 Roussel Uclaf Compounds of 1,2,5,6-tetrahydropyridine which are useful as cholinergic agents
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti
US5231107A (en) * 1987-08-21 1993-07-27 Roussel Uclaf Derivatives of the oxime of 1,2,5,6-tetrahydropyridine 3-carboxaldehyde, the process for their preparation, their use as medicaments and the compositions containing them
IT1222526B (it) * 1987-08-21 1990-09-05 Roussel Maestretti Spa Derivati dell' ossima della 1,2,5,6-tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
DK177889A (da) * 1988-04-15 1989-10-16 Beecham Group Plc Hidtil ukendte forbindelser
US5278170A (en) * 1989-04-13 1994-01-11 Beecham Group P.L.C. Azabicylo oxime compounds
ATE269330T1 (de) * 1989-04-13 2004-07-15 Beecham Group Plc Chemische verbindungen
IT1240603B (it) * 1990-03-14 1993-12-17 Roussel Maestretti Spa Derivati della 1,2,5,6-tetraidropiridina 3- carbossaldeide ossima, loro procedimento di preparazione e loro impiego come sostanza medicinale
IT1241138B (it) * 1990-05-15 1993-12-29 Roussel Pharma Derivati dell'ossina della 1,2,5,6- tetraidropiridin-3-carbossaldeide,loro procedimento di preparazione e loro impiego come sostanze medicinali
IE912974A1 (en) * 1990-08-24 1992-02-26 Beecham Group Plc Novel compounds
GB9019095D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
WO1992006959A1 (en) * 1990-10-12 1992-04-30 Beecham Group Plc 1,2,5,6-tetrahydropyridine oxime derivatives
US5175166A (en) * 1991-08-27 1992-12-29 The University Of Toledo Muscarinic agonists
AU3142793A (en) * 1991-12-18 1993-07-19 Warner-Lambert Company Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia
ZA931109B (en) * 1992-03-04 1993-09-22 Akzo Nv Tetrahydropyrimidine derivatives.
US5208343A (en) * 1992-03-24 1993-05-04 Warner-Lambert Company Tetrahydropyridine oxime compounds
ZA937382B (en) * 1992-10-06 1994-04-29 Warner Lambert Co Novel composition for peroral therapy of cognitionimpairment and a process therefor
WO1994007493A1 (en) * 1992-10-06 1994-04-14 Warner-Lambert Company Stabilized compositions containing 1,2,5,6-tetrahydro-1-methyl-3-pyridinecarboxyaldehyde-o-methyl-oxime
AU5628194A (en) * 1992-11-27 1994-06-22 Akzo N.V. 1,3-diazacycloalkyl oxime derivatives
US5362860A (en) * 1993-02-01 1994-11-08 Warner-Lambert Company Neutral stabilization complex for CI-979 HCl, a cognition activator
US5424301A (en) * 1993-02-01 1995-06-13 Warner-Lambert Company Starch stabilized o-substituted tetrahydropyridine oxime cholinergic agents
US5618818A (en) * 1996-03-20 1997-04-08 The University Of Toledo Muscarinic agonist compounds
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
WO2004101422A2 (en) * 2003-05-13 2004-11-25 Oasis Corporation Combined water cooler and refrigerator unit
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
EP2258358A3 (de) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenese mit Acetylcholinesterasehemmer
CA2620333A1 (en) * 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2007075297A2 (en) * 2005-12-27 2007-07-05 University Of Toledo Muscarinic agonists and methods of use thereof
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20110294835A1 (en) 2008-05-15 2011-12-01 The Board Of Trustees Of The University Of Illinois Muscarinic Agonists as Cognitive Enhancers
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012149524A1 (en) 2011-04-29 2012-11-01 The University Of Toledo Muscarinic agonists as enhancers of working memory and cognitive flexibility

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889074A (en) * 1959-02-12 1962-02-07 Ciba Ltd New pyridine derivatives and process for their manufacture
FR1258847A (fr) * 1960-02-12 1961-04-21 Ciba Geigy Procédé de préparation de nouveaux dérivés pyridiniques, entre autres de l'oxime de la l-méthyl-3 ou 4-acétyl-1, 2, 5, 6-tétrahydropyridine
JPS511638A (ja) * 1974-06-27 1976-01-08 Fujisawa Pharmaceutical Co Shokubutsuseichochoseizai
US4297359A (en) * 1978-07-25 1981-10-27 Acf Chemiefarma Nv Anti-ulcer compositions containing certain pyridyl oxime ethers
IL81610A (en) * 1986-02-27 1990-12-23 Roussel Uclaf Derivatives of 1,2,5,6-tetrahydropyridin-3-carboxaldehyde oxime,their preparation and pharmaceutical compositions containing them
US4710508A (en) * 1986-12-08 1987-12-01 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1203971B (it) * 1987-04-24 1989-02-23 Roussel Maestretti Spa Derivati di 1,2,5,6-tetraidropiridina, loro procedimento di preparazione e loro applicazione come medicamenti

Also Published As

Publication number Publication date
DE3785312D1 (de) 1993-05-13
DE3785312T2 (de) 1993-07-22
FI85467C (fi) 1992-04-27
NO172045C (no) 1993-06-02
KR880007466A (ko) 1988-08-27
NO172045B (no) 1993-02-22
NO875082L (no) 1988-06-09
PT86311B (pt) 1990-11-07
FI875363A (fi) 1988-06-09
AU607442B2 (en) 1991-03-07
AU8110287A (en) 1988-06-09
EP0271798B1 (de) 1993-04-07
DK638487A (da) 1988-06-09
NO875082D0 (no) 1987-12-07
DK638487D0 (da) 1987-12-04
NZ222756A (en) 1989-10-27
EP0271798A3 (en) 1989-01-18
EP0271798A2 (de) 1988-06-22
PT86311A (en) 1988-01-01
US4786648A (en) 1988-11-22
FI875363A0 (fi) 1987-12-04
FI85467B (fi) 1992-01-15
KR960000072B1 (ko) 1996-01-03

Similar Documents

Publication Publication Date Title
PH23404A (en) Q-substituted tetrahydropyridine oxine cholinergic agents
ZA878506B (en) O-substituted tetrahydropyridine oxime cholinergic agents
GB8706229D0 (en) Box
EP0256463A3 (en) Improved token passing network
GB8625103D0 (en) Disinfectant compositions
NZ222047A (en) Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
GB2187097B (en) Disinfectant compositions
GB8609331D0 (en) Anti-arrythmia agents
GB8727410D0 (en) Inorganic oxide fibres
GB2193992B (en) Barrier
ZA874587B (en) Dihydropyridines
GB2239598B (en) Decontaminant composition
GB2227272B (en) Barrier
GB8607160D0 (en) Disinfecting compositions
GB8618942D0 (en) Box
GB8709400D0 (en) Acetylcholinesterase
ZA879327B (en) Substituted benzamides
GB2192613B (en) Box construction
GB8616126D0 (en) Barrier
IE873024L (en) O-substotuted tetrahydropyridine oxime cholinergic agents
KR890008661Y1 (en) Deep-pump box
GB8600587D0 (en) Security box
GB8600586D0 (en) Security box
CS1002086A1 (en) Sposob pripravy nitrilu kyseliny n benzyl 4 fenyl piperidin 4 karboxylove
CS555586A1 (en) Sposob vyroby krystalickeho zeolitu typu zsm 5